JP2007510718A5 - - Google Patents

Download PDF

Info

Publication number
JP2007510718A5
JP2007510718A5 JP2006539449A JP2006539449A JP2007510718A5 JP 2007510718 A5 JP2007510718 A5 JP 2007510718A5 JP 2006539449 A JP2006539449 A JP 2006539449A JP 2006539449 A JP2006539449 A JP 2006539449A JP 2007510718 A5 JP2007510718 A5 JP 2007510718A5
Authority
JP
Japan
Prior art keywords
compound
substituted
nitrogen
cancer
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006539449A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007510718A (ja
JP4717003B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/011638 external-priority patent/WO2005056531A1/en
Publication of JP2007510718A publication Critical patent/JP2007510718A/ja
Publication of JP2007510718A5 publication Critical patent/JP2007510718A5/ja
Application granted granted Critical
Publication of JP4717003B2 publication Critical patent/JP4717003B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006539449A 2003-11-12 2004-04-16 11−o−メチルゲルダナマイシン化合物 Expired - Fee Related JP4717003B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51947903P 2003-11-12 2003-11-12
US60/519,479 2003-11-12
PCT/US2004/011638 WO2005056531A1 (en) 2003-11-12 2004-04-16 11-o-methylgeldanamycin compounds

Publications (3)

Publication Number Publication Date
JP2007510718A JP2007510718A (ja) 2007-04-26
JP2007510718A5 true JP2007510718A5 (enExample) 2007-06-14
JP4717003B2 JP4717003B2 (ja) 2011-07-06

Family

ID=34676572

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006539449A Expired - Fee Related JP4717003B2 (ja) 2003-11-12 2004-04-16 11−o−メチルゲルダナマイシン化合物

Country Status (5)

Country Link
US (1) US6870049B1 (enExample)
EP (1) EP1682514A4 (enExample)
JP (1) JP4717003B2 (enExample)
CA (1) CA2545457A1 (enExample)
WO (1) WO2005056531A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7259156B2 (en) * 2004-05-20 2007-08-21 Kosan Biosciences Incorporated Geldanamycin compounds and method of use
WO2007059116A2 (en) * 2005-11-14 2007-05-24 Abraxis Bioscience, Inc. Geldanamycin derivatives and pharmaceutical compositions thereof
WO2007098229A2 (en) * 2006-02-21 2007-08-30 Michigan State University Geldanamycin derivatives and method of use thereof
DE102006044472A1 (de) * 2006-09-21 2008-04-03 Discovery Partner International Gmbh Geldanamycin-Derivate
EP2200653A2 (en) 2007-09-10 2010-06-30 University of Massachusetts Mitochondria-targeted anti-tumour agents

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987035A (en) 1974-04-05 1976-10-19 University Of Illinois Foundation Biologically active compounds
US4261989A (en) 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
JPS5874651A (ja) 1981-09-17 1983-05-06 Takeda Chem Ind Ltd マクベシン誘導体およびその製造法
US4421687A (en) 1981-09-26 1983-12-20 Takeda Chemical Industries, Limited Macbecin derivatives
JPS59102398A (ja) 1982-12-03 1984-06-13 Takeda Chem Ind Ltd 新規抗生物質およびその製造法
JPS63218620A (ja) 1987-03-09 1988-09-12 Kyowa Hakko Kogyo Co Ltd 癌化細胞の正常化剤
JPH0446120A (ja) 1990-06-11 1992-02-17 Kyowa Hakko Kogyo Co Ltd 血管新生抑制剤
BR9207024A (pt) 1992-01-06 1995-12-05 Pfizer Processo e utilizações para 4,5-DI-hidrogeldanamicina e sua hidroquinona
JPH08502488A (ja) 1992-10-14 1996-03-19 アメリカ合衆国 前立腺癌および初期神経悪性疾患に対するベンゾキノイドアンサマイシンの殺腫瘍活性
US5387584A (en) 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
CA2166320A1 (en) 1993-06-29 1995-01-12 Randall James Gallaschun Ansamycin derivatives as antioncogene and anticancer agents
US5932566A (en) 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
US5662883A (en) 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5534270A (en) 1995-02-09 1996-07-09 Nanosystems Llc Method of preparing stable drug nanoparticles
US5510118A (en) 1995-02-14 1996-04-23 Nanosystems Llc Process for preparing therapeutic compositions containing nanoparticles
CA2218523A1 (en) 1995-05-02 1996-11-07 William J. Welch Inducement of thermotolerance with benzoquinonoid ansamycins
JP2002520369A (ja) 1998-07-17 2002-07-09 アメリカ合衆国 水溶性薬剤およびその製造方法
US6682758B1 (en) 1998-12-22 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services Water-insoluble drug delivery system
WO2002036574A1 (en) * 2000-11-06 2002-05-10 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Geldanamycin derivatives useful for the treatment of cancer
JP4213472B2 (ja) * 2001-03-30 2009-01-21 アメリカ合衆国 ゲルダナマイシン誘導体及びそれを用いる癌の治療方法
AU2002330998A1 (en) 2001-08-06 2003-02-24 Kosan Biosciences, Inc. Benzoquinone ansamycins
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
WO2003066005A2 (en) * 2002-02-08 2003-08-14 Conforma Therapeutics Corporation Ansamycins having improved pharmacological and biological properties
KR20050119665A (ko) * 2003-03-28 2005-12-21 코산 바이오사이언시즈, 인코포레이티드 재발협착증을 예방하기 위한 장치, 방법 및 조성물

Similar Documents

Publication Publication Date Title
JP2010504346A5 (enExample)
JP2006505543A5 (enExample)
JP2010531304A5 (enExample)
KR101982951B1 (ko) 신규한 유형의 시티딘 유도체 및 그의 용도
JP2011509949A5 (enExample)
JP2008510770A5 (enExample)
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
JP2004506606A (ja) 抗ウイルスピリミジンヌクレオシド類
JP2008535902A5 (enExample)
JP2014500870A5 (enExample)
JP2009504764A5 (enExample)
JP2009504763A5 (enExample)
CA2605738A1 (en) Novel azaheterocyclic compounds as kinase inhibitors
JP2005533835A5 (enExample)
JP2011509309A5 (enExample)
JP2013532652A5 (enExample)
RU2020102453A (ru) Фармацевтические композиции
WO2005113537B1 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
RU2011133128A (ru) Противоопухолевые соединения дигидропиран-2-она
JP2006501201A5 (enExample)
JP2007520452A5 (enExample)
JP2002527414A5 (enExample)
JP2009539943A5 (enExample)
JP2019519593A5 (enExample)
JP2007502832A5 (enExample)